COMPOUNDS USEFUL FOR TREATING INJURIES FROM WARFARE AGENTS
申请人:Wu Xinyuan
公开号:US20150352115A1
公开(公告)日:2015-12-10
Compounds and compositions for treating disorders related to TRPA1 are described herein.
本文描述了用于治疗与TRPA1相关的疾病的化合物和组合物。
Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists
作者:Harrie J.M. Gijsen、Didier Berthelot、Michel A.J. De Cleyn、Ivo Geuens、Bert Brône、Marc Mercken
DOI:10.1016/j.bmcl.2011.12.068
日期:2012.1
The transient receptor potential A1 (TRPA1) channel has been implicated in a number of inflammatory and nociceptive processes, and antagonists of the TRPA1 receptor could offer a potential treatment for conditions such as inflammatory or neuropathic pain, airway disorders, and itch. In a high throughput screen aimed at the identification of TRPA1 antagonists, 4-phenyl-2-thioxo-1,2,3,4-tetrahydroindeno[1,2-d]pyrimidin-5-one (1) was identified as a potent TRPA1 receptor antagonist. A series of analogous tricyclic 3,4-dihydropyrimidine-2-thiones has been prepared via the multi-component Biginelli reaction and subsequent derivatization. This has led to TRPA1 antagonists with potencies around 10 nM for both rat and human derived TRPA1 receptors. The activity was shown to reside exclusively in the 4R-enantiomers. (C) 2011 Elsevier Ltd. All rights reserved.
An Efficient and Modified Biginelli-Type Synthesis of 3,4-Dihydro-1H-indeno[1,2-d]pyrimidine-2,5-dione Using Phosphorous Pentoxide
作者:Poojali P. Warekar、Govind B. Kolekar、Madhukar B. Deshmukh、Prashant V. Anbhule
DOI:10.1080/00397911.2014.947652
日期:2014.12.17
A simple, clean and convenient one-pot method has been developed for the synthesis of 4-phenyl-3,4-dihydro-1H-indeno[1,2-d]pyrimidine-2,5-dione and 4-phenyl-2-thioxo-1,2,3,4-tetrahydro-5H-indeno[1,2-d]pyrimidine-5-one by multicomponent condensation of 1,3-indanedione, aromatic aldehydes and urea/thiourea using phosphorus pentoxide in ethanol under reflux conditions. The simple workup procedure and moderate to good yields within short time are some important features of this protocol. The synthesized compounds have been interpreted on the basis of their spectroscopic data.
COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO TRPA1
申请人:Wu Xinyuan
公开号:US20160009708A1
公开(公告)日:2016-01-14
Compounds and compositions for treating disorders related to TRPA1 are described herein.